The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials.
By David Moher, K. F. Schulz, Douglas G. Altman. Journal of the American Podiatric Medical Association (Print), 2001
2,226 citations recorded by the source corpus.
Subfields: Economics and Econometrics, Statistics and Probability
View Paper: https://www.semanticscholar.org/paper/0c633c82971b552d67c61b77836d1f80e4a2747f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Economics and Econometrics
- Douglas G. Altman
- David Moher
- K. F. Schulz
- Stanley E. Lazic
- Matthias Egger
- S. Taube
- Lisa M. McShane
- Willi Sauerbrei
In Statistics and Probability
- Douglas G. Altman
- David Moher
- K. F. Schulz
- Stanley E. Lazic
- Matthias Egger
- S. Taube
- Lisa M. McShane
- Willi Sauerbrei
Citations in the corpus
- Reporting guidelines for controlled experiments in software engineering (2005, background): “, for randomized controlled trials in biomedical research [4], [15], clinical practice guidelines [16], and empirical results from psychological research [17].”
- How can we increase translation of research into practice? Types of evidence needed. (2007, background): “ports in the same way that CONSORT criteria are now reported routinely (49, 74).”
- Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test. (2004, methodology): “A test for interaction between treatment and subgroup is the appropriate way to examine whether treatment effects differ between subgroups [1,3,4,12–15].”
- Guidance for Developers of Health Research Reporting Guidelines (2010, methodology): “We convened a one-day meeting to update the CONSORT Statement and two-day meeting to update QUOROM (subsequently published as the PRISMA Statement).”
- Effects of face-to-face restorative justice on victims of crime in four randomized, controlled trials (2005, methodology): “By providing the full CONSORT statement ( Moher et al. 2001 ) description of each of the four RCTs for which we report these common criterion measures, the analysis simultaneously accomplishes elements of both primary and meta-analysis.”
- Standards of Evidence: Criteria for Efficacy, Effectiveness and Dissemination (2005, methodology): “An exemplary standard format can be found in the CONSORT statement adopted by the journals of the American Medical Association ( Moher et al., 2001 ).”
- Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? (2003, neutral): “Sample size Median (range)* 120 (10-14 046) 55 (12-497) 178 (13-82 892) 110 (11-3575)”
- Reporting recommendations for tumor marker prognostic studies. (2005, methodology): “Ideas were also generated by reviewing similar reporting guidelines that have been produced for other types of medical research studies (CONSORT, Quality of Reporting of MetaAnalyses [QUOROM], Meta-analysis Of Observational Studies in Epidemiology [MOOSE], and STARD).(34,38,39,35) Three individuals ”
- Algorithm for neuropathic pain treatment: An evidence based proposal (2005, neutral): “…authors to: (1) report the trial to a central database (DeAngelis et al., 2004); (2) to follow Good Clinical Practice (GCP) requirements (ICH, 1997; Jorgensen et al., 2004); (3) to follow the guidelines in the consort statement (Moher et al., 2001); (4) to do more head-to head comparisons.”
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration (2012, methodology): “Thus the CONSORT flow diagram [8] has become a widely used simple depiction of the flow of participants in an RCT from enrolment through to inclusion in the final analysis.”